Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema

• Status: Completed
• Trial end date: 2013-12-01

Summary

Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema

• Phase: Phase 4

Details

• Lead Sponsor: Rubens Belfort Jr.
• Treatments: Bevacizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide